Flawed oxygen readings possibly behind COVID-19 toll on people of color in U.S.: Politico


By Xia Lin

NEW YORK, July 5 (Xinhua) -- Doctors have sometimes failed to diagnose serious cases of COVID-19 among people of color, and the U.S. Food and Drug Administration (FDA) acknowledges one reason may be flaws in devices it approved to measure blood oxygen levels, reported Politico on Saturday.

"Pulse oximeters can overestimate blood oxygen in people with dark skin, causing doctors to miss patients' distress signals," said the report.

The FDA is convening an expert advisory panel later this year to assess the problem and offer guidance to health care providers. An agency spokesperson said it has prioritized assuring that pulse oximeters are "sufficiently safe and accurate for all people," according to the report.

"But advocates still say the FDA, which issued a warning about the issue last year, is moving too slowly," said the report.

The problem raises broader concerns about bias as technology becomes more embedded in health care, and about the government's ability to counteract it through regulation and oversight, it added.

Article type: free
User access status:
Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!
   

Next In World

Japan's Kishida likely to retain finance and foreign ministers in reshuffle - Nikkei
Ukraine hopes for Germany's help in getting 8 bln euros from EU
Brazil's analysts cut 2022 inflation forecast to 7.11 pct
U.S.-listed Chinese firms trade mostly lower
Feature: Int'l art festival in Southern California showcases Chinese traditional drama
Kenyans, desperate for change, must choose new president from familiar faces
U.S. agricultural futures close mixed
U.S. stocks end mixed as tech lags
Roundup: Hot, dry conditions continue to batter Europe, with health and economic impacts
Oil prices bounce after downbeat week

Others Also Read